Emmanuel Addo-Yobo is Associate Professor of Child Health at the School of Medical Sciences (SMS), College of Health Sciences, Kwame Nkrumah University of Science and Technology (KNUST), and Honorary Consultant Paediatrician, Child Health Directorate, KomfoAnokye Teaching Hospital (KATH), Kumasi, Ghana. He has over 25 years’ experience in child health care in Ghana with primary clinical interests in Childhood Asthma, Childhood Immunization/Vaccine preventable Disease Surveillance and Child Survival initiatives. He has a number of published research activities on childhood asthma in Ghana (collaboration the North West Lung Centre, Manchester, and the Tropical Health and Education Trust, UK), and also on treatment options for childhood pneumonia and common young infant infections in developing countries (USAID/WHO sponsored). He is currently Head of the Department of Child Health, SMS-KNUST and Directorate of Child Health, KATH, as well as Head, Quality Assurance and patient safety, KATH.
Prof.Dr., Department of Pulmonary Diseases, Atatürk University School of Medicine, Erzurum, Turkey
Dr. Metin Akgun works as educator/clinician/researcher at Atatürk University since 2003. His scientific interests are COPD, diffuse parenchymal lung diseases, pulmonary vascular diseases and sleep medicine. Silicosis due to Jean Sandblasting has become his main interest area following the epidemics in Turkey in the 2000s. He served as Chair of Occupational and Environmental Assembly of Turkish Thoracic Society between 2016 and 2018. Currently, he is the Chief Editor of Turkish Thoracic Journal, which is indexed in Pubmed Central and Thompson’s Emerging Science Citation Index, and National Delegate of European Respiratory Society for the 2017-2020 period.
Dr Joseph AmoloAluoch F.R.C.P (Edin), (Glasgow) Vice President PATS. Medical Practice for 50 years. Respiratory Medicine and Infectious diseases/HIV Medicine. Consultant Pulmonologist at the Nairobi Hospital Patron: Kenya Lung Association. Kenya Association of Physician. Chairman: HIV Clinicians Society of Kenya. Past Chairman of several medical association and societies. Overseas Representative – Royal College of Physicians of Edinburgh. Past Vice President – Commonwealth Medical Association.
Developed the ten years programme for expanded program on immunization in Kenya
Co-ordinator of National Tuberculosis control programme in Kenya 1976 to 1986 and was responsible for the development of the Curriculum for the Training of Clinical Officer TB and Leprosy (COTULEP). He was also Honorary Lecture department of Medicine University of Nairobi 1976-1986.
Senior Consultant Chest Disease at the National Hospital 1975 to 1986. World Health Organization Honorary Consultant in Tuberculosis and had consultancy assignment in Liberia Monrovia, Addis Ababa Ethiopia and Malawi facilitated TB programme development in Malawi and training of TB healthcare workers in Nairobi, Kenya. Honorary member the IUATLD
Jules Bashi Bagendabanga
Expertise: Global HIV programs, Health systems strengthening, Strategic information, Research and business development.
Jules Bashi (MD, MPH) is an experienced infectious disease specialist with more than 10 years clinical and programmatic experience in planning, design and implementation of comprehensive HIV/AIDS Treatment, Care & Support programs. He has great knowledge of improvement of health information system including research and evaluation. He has had experience working on CDC, GFATM and USAID funded projects both in central and west Africa. For pulmonary disease, Jules Bashi has keen interests in tuberculosis topics: co-infection TB/HIV, TB among Key populations, service integration, access to laboratory, quality of care, national training tools development, health policies review process and continuous quality improvement.
Eric Bateman is the founder of the University of Cape Town Lung Institute, which he served as Director until 2017. He was the Head of the Division of Pulmonology at University of Cape Town and Groote Schuur Hospital from 1989 to 2012. He is a fellow of the Royal College of Physicians, a Life Fellow of the University of Cape Town, a founding Fellow of the European Respiratory Society and an honorary fellow of the South African Thoracic Society. His primary research contributions have been in the pharmacology and management of asthma and chronic obstructive pulmonary disease (COPD), and in the development of community-based interventions to improve the care of patients with chronic diseases, with a focus on low resource settings. He has authored more than 350 peer-reviewed papers, serves on the editorial boards of several international respiratory journals.
Dr Amsalu Bekele Binegdie, Assistant Professor and Consultant Pulmonologist at College of health Sciences Addis Ababa University, Ethiopia. Published many papers on peer reviewed local & International articles on reputable journals. Currently I am involved in project like Severe Asthma in Africa project and Lung health in Africa across the life course bother are multi-country project. My research interest area is on, Tuberculosis, Asthma & Other NCDs. I am a member of Technical working group at national level for TB, TB/HIV & MDR-TB, NCD and Chair of review committee for new Anti-TB drug introduction. Current president of Ethiopia Thoracic Society.
Professor and Principal Specialist in the Department of Paediatrics and Child Health at the University of KwaZulu-Natal’s Nelson R. Mandela School of Medicine. She is Head of the Paediatric Infectious Diseases and HIV Unit. She has been involved in the care of, and research into, children with HIV infection since 1989, and has published widely in the field of paediatric HIV infection. She is a founder member of the South African Society for Paediatric Infectious Diseases, and is a past president of the South African Paediatric Association. She is a co-PI for the Medical Education Partnership Initiative (MEPI) of the University of KwaZulu-Natal.
Keertan Dheda is Professor of Respiratory Medicine, and Head of the Division of Pulmonology at the University of Cape Town. His research work focuses on the epidemiology, diagnosis, transmission, and treatment of TB. He is National Research Foundation A-rated scientist (H index = 63) and has published over 220 peer-reviewed papers including 4 first or senior author original publications in The Lancet. He has been the recipient of several prestigious awards including the International Union Against Tuberculosis and Lung Disease Scientific Award. He serves on the editorial board of several journals including the American Journal of Respiratory and Critical Medicine, and Lancet Respiratory Diseases amongst others. He holds 5 patents related to new TB control technologies. He serves on several national and international academic and advisory bodies, and is the current president of the South African Thoracic Society.
Ali Esmail is a Specialist Physician and Pulmonologist at the University of Cape Town Lung Institute, and at the Respiratory Clinic at Groote Schuur hospital. He also heads the Clinical Trials Unit at the Lung Infection and Immunity Unit, which channels all research activities within the Unit and the Division of Pulmonology. Dr Esmail has a number of niche interests in pulmonology, and has recently been awarded the EDCTP career development fellowship for his PhD on diagnostic and management of drug-resistant TB. He also runs the interventional pulmonology service at Groote Schuur Hospital which includes procedures like thoracic ultrasound guided procedures, bronchial, endobronchial ultrasound-guided mediastinal biopsy procedure (EBUS TBNA), medical thoracoscopy, bronchial thermoplasty and insertion of long-term tunnelled pleural catheters.. He uses thoracic and critical care ultrasound in routine practice and provides ultrasound training for medical registrars and fellows specializing in pulmonology.
He is aprofessor of paediatric respiratory medicine at the University of Ibadan, Ibadan, Nigeria. He is also an honorary consultant paediatrician to the University College Hospital, Ibadan. His main interest is in the field of pneumonia and asthma. He was an investigator in Nigeria in the International Study of Asthma and Allergy in Childhood (ISAAC), an international multicentre collaborative epidemiological study. He took part in the multi-centre study of Invasive Pneumococcal Diseases in the under-5s in Ibadan, Nigeria. This study showed that pneumococcal disease was an important cause of morbidity and mortality in Nigerian children, a fact that was not hitherto recognized. He is one of the two Vice-Presidents of the African Society for Paediatric Infectious Diseases (AfSPID) and also a member of Board of World Society for Pediatric Infectious Diseases.
Professor Charles Feldman obtained his MB BCh degree at the University of the Witwatersrand, in Johannesburg, South Africa and subsequently received his FCP (SA) from the College of Medicine of South Africa and his PhD and DSc (senior doctorate) degrees from the University of the Witwatersrand. He was registered as a sub-specialist in Pulmonology in 1993 and was elected to the Fellowship of the Royal College of Physicians (FRCP) in 1997. He is a member of a number of national and international societies and has been President of the South African Thoracic Society on 2 previous occasions. Professor Feldman is an NRF A-rated scientist and undertakes both clinical and basic research.
Stephen Gordon was educated at the University of Cambridge and trained in General Medicine in Oxford, Zambia and Belfast. He specialised in Respiratory Medicine in Sheffield (Clinical Lecturer) and competed Wellcome Trust Training and Intermediate Fellowships studying susceptibility to pulmonary infections in Malawi. Stephen Gordon worked at the Liverpool School of Tropical Medicine from 2005-15. He led the LSTM Respiratory Group who developed themes of research targeting vaccine discovery and testing, pathogenesis and the treatment of pneumococcal disease, using human samples from both healthy volunteers and patients. The team developed an Experimental Human Pneumococcal Carriage (EHPC) model in which healthy volunteers were challenged with pneumococci in order to study the immunological correlates of carriage, protection and clearance. Current work to exploit the EHPC model is underpinned by an MRC Programme grant. The LSTM group also developed studies of the effect of biomass fuel smoke on defence against infection. An MRC Partnership grant (BREATHE Africa) links a large cook stove trial in Malawi with other studies of household air pollution in both the UK and Africa. Stephen has recently taken up his appointment as Director of the Malawi Liverpool Wellcome Programme of Clinical Tropical Research. Under his leadership, the MLW Programme will work with the College of Medicine and partners to develop leaders in translational research with substantial health impact in Malawi and the region. Our focus areas of research include TB and pneumonia, prevention of chronic lung disease, vaccination and household pollution.
Dr Diane Gray is a paediatric pulmonologist and clinical researcher in the Department of Paediatrics, Red Cross War Memorial Children’s Hospital, University of Cape Town. Her research focuses on better understanding the determinants of chronic lung disease in African children and the development of appropriate preventive and management strategies. Her interests include Paediatric HIV lung disease, TB and bronchiectasis. She has setup infant and preschool lung function testing in Africa, and contributed to international collaborations developing tools for preschool lung function testing. She is co-investigator of the Paediatric and Adult African Spirometry (PAAS) project. She currently holds a Wellcome Trust intermediate fellowship for research investigating the impact of early life exposures on chronic respiratory illness in African children and is the proud mum of Nate and Ben.
Jonathan Grigg BSc, MB BS, MRCP, MD, FRCPCH; is Professor of Paediatric Respiratory and Environmental Medicine at Queen Mary University of London, and an honorary consultant respiratory paediatrician at the Royal London Hospital. His recent research has focused on the effects of air pollution and the treatment of wheeze in young children. He leads a European Respiratory Society Clinical Research Collaboration (CRC) on improving recruitment of children into trials of biologics for asthma. He is a member of the Department of Health’s Committee on the Medical Effects of Air Pollution, and in 2016 launched the advocacy group “Doctors against Diesel”.
Dr. Hopewell is Professor of Medicine, emeritus at the University of California, San Francisco (UCSF) and practices pulmonary and critical care medicine at San Francisco General Hospital (SFGH). He is a former Associate Dean of UCSF, being responsible for the academic programs at SFGH and is currently the director of the Curry International Tuberculosis Center at UCSF, which provides education, technical assistance, and training in TB to domestic and international audiences. In addition he is a previous President of the American Thoracic Society. His academic career has focused on clinical and epidemiological studies of tuberculosis and HIV-associated pulmonary conditions in both low-incidence and high-incidence settings. In the early days of the HIV epidemic in San Francisco, Dr. Hopewell and his colleagues described many of the pulmonary manifestations of HIV. He has had a long-running community-based study of the molecular epidemiology of tuberculosis in San Francisco. Currently, He has been very involved in providing technical advice to the World Health Organization and dozens of national TB programs on a variety of programmatic policies.
Dawit is an internist, pulmonologist and critical care specialist. He is an assistant professor in the department of Internal Medicine, College of Health Sciences, Addis Ababa University, where he serves as a medical educator and clinical researcher. He did my fellowship in Pulmonary and Critical Care Medicine from Addis Ababa University in February 2017. This is a two year training program hosted by the university and supported by East African Training Initiative (EATI, www.eati.org). He is entitled Director of the Intensive Care Unit of TikurAnbessa Specialized Hospital, the biggest tertiary teaching hospital in Ethiopia. He is also Executive Committee member of the Ethiopian Society of Internal Medicine (ESIM) and the Ethiopian Thoracic Society. He attended PATS MECOR level 1 in Blantyre, Malawi.
Professor Mohamed Jeebhay, is an Occupational Medicine specialist, and holds joint appointments as Head of the Occupational Medicine Division in the School of Public Health and Family Medicine as well as in the Department of Medicine at the University of Cape Town (UCT). His major research interest is in the field of allergens and asthma with a major focus on environmental risk factors and preventive approaches for occupational allergy and asthma. He serves as editorial board member of the Journal of Current Allergy and Clinical Immunology, and the South African Respiratory Journal. He is a fellow of the Collegium Ramazzini, an international academy of internationally renowned fellows in occupational and environmental health (2011-present). The National Research Foundation of South Africa has rated him as an internationally acclaimed (B2-rated) research scientist.
Professor Jeena is the Head of Paediatric Pulmonology and Critical Care at the Inkosi Albert Luthuli Central Hospital, Durban, South Africa. He has completed his PhD on viral infections among HIV infected and uninfected children with severe and severe pneumonia. He has worked with the World Health Organisation on the Essential Medicines List and with the international Union against Tuberculosis and Lung Disease on developing treatment guidelines for tuberculosis in HIV infected children. He serves as a ministerial appointment on the National Advisory Group on Immunisation and as vice chair on the Essential Drugs Program for children. Prof Jeena has published extensively in highly reputable journal including Lancet and the Pediatric Infectious Disease Journal. He is editor for medical journals and is involved in undergraduate and postgraduate student supervision.
Ashley Clement Jeevarathnum is a paediatric pulmonologist in private practice at the Clinton hospital Johannesburg. He is also a part time lecturer and consultant at the department of paediatric pulmonology, university of pretoria. Ashley Jeevarathnum underwent training at the university of pretoria which is headed by Professor Robin Green. His interests include interstitial lung diseases, cystic fibrosis amongst others.
Lecturer Department of Medicine Makerere University & Director Makerere University Lung Institute. Former Head of Pulmonology Unit Department of Medicine. Pulmonologist with current active research in airway and environmental lung diseases. Also an active investigator in Tuberculosis. Authored over 30 publications in peer reviewed journals (Member of the Uganda Thoracic Society and Uganda Physician association. Have presented several scientific paper at both local and international conferences. Chaired several sessions at local and international conferences.
Alison qualified as a physiotherapist from the University of Cape Town in 2007. She went on to obtain her PhD at UCT with her dissertation entitled “Ventilation distribution in infants and children: its determinants and distribution” in 2017. Alison is currently a Postdoctoral Research Fellow in the Division of Physiotherapy at Stellenbosch University and is investigating the long term outcomes of critical illness survivors in South Africa. She is also involved in teaching in the Division of Physiotherapy at UCT and serves on both the national and provincial committees of the Cardiopulmonary Rehabilitation Group of the South African Society of Physiotherapy. She has a special interest in both paediatric and adult cardiorespiratory physiotherapy and rehabilitation, the role of physiotherapy in critical care, and the role of physiotherapy in health promotion.
Undergraduate training at The University of Natal, post graduate training in cardiothoracic surgery at Wentworth and King George V Hospital in Durban. Clinical Head Cardiothoracic Surgery, University of KwaZulu Natal. Interests: Surgery for coronary artery disease and inflammatory lung disease.
Research Interests: Lung resection for TB, pathogenesis of TB in the human lung.
Prof Masekela obtained her undergraduate medical training at Wits University in 1997 and completed her internship and community service at Polokwane/Mankweng Hospital complex. She then completed her postgraduate training with a Masters in Paediatrics at the University of Pretoria in 2005, after which she went on to sub-specialize in Paediatric Pulmonology at the University Hospitals Leuven in Belgium and at the University of Pretoria. She then completed her PhD (Paediatrics) titled “Chronic inflammatory lung disease in children with human immunodeficiency virus- Epidemiological considerations, aetiological determinants and the efficacy of low dose erythromycin in bronchiectasis”; which she completed at the University of Pretoria in 2012. She was also elected as a Fellow of the College of Chest Physicians by peer-review. She is an executive member of the South African Thoracic Society and is at present the past chairperson of the National Asthma Education Program. She is the secretary of the Pan African Thoracic Society and an executive member of the on the Scientific Advisory Committee of the South African Cystic Fibrosis, Allery Society of South Africa and the South African Paediatric Association. She currently holds the position of Associate Professor and Head of Maternal and Child Heath at the University of KwaZulu-Natal. She has research interest in asthma in Africa, CF and non-CF bronchiectasis in children.
Dr Iqbal Master graduated from the Nelson Mandela School of Medicine in 1986. He currently holds the position of Clinical Manager and Head of Department of the MDR TB Unit at King Dinuzulu Hospital, Durban. (previously King George V Hospital). He has 23 years of experience in the management of MDR and XDR TB. He is a member of both the Provincial and National Drug Resistant TB Advisory Committee. He has been involved in multiple studies in Drug Resistant TB.
Rajen Nithiseelan Naidoo, an Associate Professor and Head of Department in Occupational and Environmental Health at the University of KwaZulu-Natal, has been in academic research for over 25 years. His areas of research focus on occupational and environmental respiratory diseases, with projects funded by major national and international agencies, including the National Research Foundation, US National Institutes of Health, the European Union and the AstraZeneca Trust. He has over 60 peer-reviewed publications, with presentations at several international conferences. He is on the Advisory Board of the International Archives of Occupational and Environmental Health and the American Journal of Industrial Medicine. He received his postgraduate training in occupational medicine at the University of Cape Town, and his doctorate at the University of Michigan.
Dr Naidoo is the Head of the Department of Public Health Medicine in the College of Health Sciences at the University of KwaZulu-Natal. She obtained her undergraduate medical degree from the University of Natal in 1992, became a Public Health Medicine Specialist in 2003 and is an Associate in the Division of Occupational Medicine in the College of Public Health Medicine. In 2011 she obtained her PHD from the Institute of Risk Assessment Science, Utrecht University, Netherlands. Dr Naidoo‘s research interests lie in two areas, namely environmental impacts on women’s reproductive health and child development, and Tuberculosis exposure and health outcomes in working populations. She has been funded by various agencies including, The South Africa Netherlands Research Programme on Alternatives in Development (SANPAD), The National Institute of Environmental Health Sciences (NIEHS), Danish International Development Agency (DANIDA), the South African Medical Research Council and the National Research Foundation.
Dr Rebecca Nantanda is a general Paediatrician and Senior Research Fellow at Makerere University Lung Institute (MLI). She is also the Ag. Head of Department -Training and Education at MLI. She is currently involved in research focusing on lung heath in children and developing respiratory medicine training programmes. Her research largely focuses on asthma and pneumonia in children and has a number of publications on this subject. She also serves as Honorary Lecturer in the Department of Paediatrics and Child Health, Makerere College of Health Sciences where she is involved in teaching medical students, supervising research projects and offering clinical care in the Paediatric Chest Clinic at Mulago National Referral and Teaching hospital. Rebecca is the current President of Uganda Paediatrics Association, and Executive Committee member for Uganda Thoracic Society.
Ben Nemery is holder of degrees in medicine, occupational medicine and toxicology. He has been affiliated with the Medical Faculty of the KU Leuven since 1987. He founded the research unit of Lung Toxicology, a joint venture between the departments of Pneumology and of Occupational, Environmental and Insurance Medicine. He teaches toxicology and occupational medicine, mainly at postgraduate level. He holds a weekly outpatient clinic for occupational pulmonary disorders.
His research involves experimental as well as clinical-epidemiological studies in the mechanisms of lung disease caused by occupational and environmental pollutants. Recently he has concentrated on occupational and environmental health in the South, especially Africa.
Dr Obianuju Ozoh is a Senior Lecturer and Pulmonologist at the College of Medicine, University of Lagos and the Lagos University Teaching Hospital, Lagos Nigeria. She obtained the ERS spirometry driving license and has participated in spirometry training locally in Nigeria and at PATS MECOR since 2015. She is also a faculty at the PATS MECOR program. Her research interests include the impact of chronic diseases and respiratory exposures on pulmonary function and lung health, airway diseases and tobacco epidemiology. She is currently undertaking a large-scale evaluation of pulmonary function test abnormalities among adolescents and young adults in Lagos, Nigeria.
Andrés Palomarnhas a degree in Medicine from the Faculty of Medicine of the Guadalajara Autonomous University, where he was awarded with the Title of the Best Student of his class. Andrés developed his internship at the Regional Military Hospital, he has three Specialties: Internal Medicine and Critical Medicine, both from the ABC Medical Center that is located in Mexico City and Cardio-Pneumology. This one from the National Institute of Cardiology "Ignacio Chavez", that also is located in Mexico City. Finally, he completed his academic training at the University of Manitoba, Canada, where he made his fellowship in Pulmonology and in Mexico he obtained his certification by the National Council of Pulmonology. Dr. Palomar has published more than 50 articles in scientific journals, all related to Pneumology and Intensive Therapy topics. These papers have more than 600 citations in the Science Citation Index. Also, he has written 8 chapters in books related to his specialty and has published a book named: "Influenza for the new virus A H1N1. An Integral View". Andrés has participated in several workshops about Mexican consensuses and guides, some of them about Asthma, COPD and Smoking stand out. He has been a Speaker in more than 350 lectures around 13 countries, in events organized by the Spanish Society of Pneumology and Thoracic Surgery (SEPAR), the Cuban Society of Pneumology and the American College of Chest Physicians (ACCP). He has teached in different Universities and has been member of the Governing Board of the National Institute of Respiratory Diseases since 2012. Dr. Palomar has also collaborated with the National Council of Pneumology, as a Member, Treasurer, Secretary, President (2005), President of the Examining Jury and as member of the Recertification Jury.Andrés has been an active member of the Thorax Latin American Association (ALAT), Coordinator of the Pulmonary Vascular Section in the Congress SMNYCT / ALAT (Cancun, Mexico). He has also being member of the Academic Committee for the ALAT Congress in Montevideo, Uruguay (2012). Actually Dr. Palomar is an active member of the Mexican Society of Cardiology of Mexico, the College of Medical Criticism of Mexico, and the American Thoracic Society (ATS), is a Fellow in the American College of Chest Physicians (ACCP), and now a days he´s the President of the Medical College of the ABC Medical Center, he also holds the Presidency of the ALAT since 2016.
Dr Ashendri Pillay is a Paediatric Infectious Diseases Specialist in the Department of Paediatrics and Child Health at King Edward VIII Hospital affiliated to the Nelson R Mandela School of Medicine, University of KwaZulu-Natal. She is a member of the institutions’ IPC and Antibiotic Stewardship committee; her research interests include medical management of abdominal TB and drug-drug interactions between anti-tuberculosis and antiretroviral therapy in paediatrics.
Specialist Cardiothoracic Surgeon at Inkosi Albert Luthuli Central Hospital and University of Kwa-Zulu Natal. Masters of Medicine on surgery for post intubation tracheal stenosis. Special interest in TAR OPCAB, undertook fellowship at Centre of Excellence in Kerala, India. Trained under Prof Deigo Gonzales on Uniportal VATS at the Shangai Pulmonary Institute, China. Affiliated to AHRI (African Health Research Institute ) in investigating TB and HIV related diseases.
He is a UK-trained specialist in Respiratory and General Internal Medicine and a Senior Clinical Lecturer at the Liverpool School of Tropical Medicine, UK. He has practised as a clinician scientist in the UK, Tanzania and Malawi, where his interests bridge acute and chronic respiratory illness. He is a co-investigator for the Global Challenges Research Fund (GCRF) Foundation award “Lung health in Africa through the life course,” and he oversees the building of local and international research links within this partnership, specifically in designing and deploying common tools for the assessment of lung health. We seek to use these to examine the determinants of lung health in adults. He also has a strong interest in improving acute care for adults in low income countries, including the treatment of sepsis, the use of thoracic ultrasound, and the use of effective triage and mechanisms for identifying critical illness early.
Prof H. Simon Schaaf is Distinguished Professor and Senior Specialist at the Department of Paediatrics and Child Health, Faculty of Medicine and Health Sciences, Stellenbosch University and Tygerberg Children’s Hospital, Cape Town, South Africa. He completed his doctoral degree in drug-resistant tuberculosis in children at Stellenbosch University. He co-edited the book: Tuberculosis: a comprehensive clinical reference, which was published in 2009. He is an active clinician and infectious diseases subspecialist. He has published extensively, with the emphasis of his research on childhood TB with special focus on MDR-TB and TB drug pharmacokinetics in children.
Cardiothoracic Surgeon with special interest in Minimally invasive Thoracic Surgery. Honorary Consultant University of Pretoria. Department of Cardiothoracic Surgery. Executive Member: South African Thoracic Society and Chest Wall International Group. (Founder Member). Director of numerous Video assisted thoracic surgery wet labs. (VATS)
Numerous presentations and papers. Pectus Surgeon (Introduced Nuss procedure into South Africa).
His core research direction is investigating persistence of ongoing infection in HIV and TB. His initial contribution in this field was with David Baltimore at Caltech, where he discovered that cell-to-cell spread of HIV is a persistence mechanism in the face of antiretroviral drugs (Sigal et al., Nature, 2011). In contrast to HIV infection, where viral rebound invariably occurs after the cession of therapy, TB infection may persist in a quiescent state throughout the lifetime of the individual without either clinical symptoms or disease transmission. His TB program focuses on the question of what factors determine the tipping point of TB to active disease. Using time-lapse microscopy, his laboratory observed that Mycobacterium tuberculosis (Mtb) grows most robustly when it causes serial killing of macrophages. Serial killing is initiated when a human macrophage internalizes a clump of bacilli which causes its death by necrosis. Upon death, Mtb rapidly grows in the dead cell, with a doubling time faster than either in the extracellular environment or in live cells (where growth is minimal). The next macrophage to internalize the Mtb, this time encased in a dead cell, faces a larger Mtb clump and dies with a higher frequency. The new dead cell now provides fuel for the next round of bacterial growth and bait for the next macrophage. This illustrates how, once initiated, Mtb replication can be stabilized in the active state.
Dr Sihoe received his medical training at the University of Cambridge, where he was awarded multiple prizes and received both an Honours degree and a Masters degree for research in Pathology. After working in Scotland and England, he returned to practice Cardiothoracic Surgery in Hong Kong and China, specializing in Minimally Invasive Thoracic Surgery (MITS). Dr Sihoe is now an internationally recognized advocate of ‘next generation’ MITS techniques – especially uniportal and needlescopic chest surgery. He has authored or co-authored over 150 book chapters, journal articles and conference abstracts, and his work in thoracic surgery and clinical research has won multiple awards – including from the European Society of Thoracic Surgeons (ESTS) and the International Society for Minimally Invasive Cardiothoracic Surgery (ISMICS). Today, he is one of the most widely travelled thoracic surgeons in the world, having been invited to speak and/or perform surgery at surgical conferences and educational events on every continent.
Head of Neonatal unit at King Edward Hospital/Neonatologist
MBChB (UCT); FCPaed (UKZN); Cert Crit Care Paed (UCT)
Paediatric Critical Care Specialist at Inkosi Albert Luthuli Central Hospital, KZN associated with the Nelson R Mandela School of Medicine, Dept of Paediatrics as Honorary Lecturer.
Subspecialty training at Red Cross Children’s Hospital and Great Ormond Street Children’s Hospital.
Examiner for Paediatric Critical Care Subspeciality exams.
APLS Coordinator for KZN and runs the Paediatric Tracheostomy programme at IALCH.
Heleen Van Aswegen
Heleen van Aswegen is Associate-Professor in Physiotherapy at the University of the Witwatersrand, Johannesburg, South Africa. She graduated with PhD at Wits University (2008) for a thesis titled The effect of penetrating trunk trauma and mechanical ventilation on the recovery of adult survivors after hospital discharge. Her research interest is cardiopulmonary physiotherapy especially in the fields of critical care and trauma. She has published 42 articles in peer-reviewed journals to date. Heleen has been an invited speaker at several national congresses and presented her research at international congresses such as the World Confederation of Physical Therapy and World Federation of Societies of Intensive and Critical Care Medicine over the past 10 years. She is editor of a book titled Cardiopulmonary Physiotherapy in Trauma: An Evidence-based Approach published in 2015 by Imperial College Press.
Charl Verwey established and runs the paediatric pulmonology division at Chris Hani Baragwanath Academic Hospital. He is a senior lecturer at the University of the Witwatersrand. He is currently on a sabbatical doing his PhD investigating the pulmonary sequelae of early RSV infection on the developing lung. When he is not working he tries to raise his boys, ride his bike and climb a few mountains…
Dr. Murali P Vettath is a new generation coronary surgeon – one of the handful of surgeons in the world, performing 100% of his coronary surgeries on beating heart without the use of Heart Lung Machine, over the last decade. Has trained numerous surgeons and anesthesiologists in this field of cardiac surgery around the world. Has performed 7000 plus open heart surgeries with more than 4500 OPCAB’S with a mortality of less than 0.5%. Has invented the VETTATH'S ANASTOMOTIC OBTURATOR- A proximal anastomotic device used during OPCAB surgery, which has been patented in 2004. Has developed the SIMS (Simple Indian made stabilizer)...for performing OPCAB SURGERY, which has been sent for patenting in 2015. Has over the years innovated, fabricated, developed and modified different technics and technology to perform OPCAB surgery. Performed three Heart transplantations in 2015 of which two are still surviving. First of its kind in north Kerala. Has delivered Invited lectures in 20 countries. Has operated and demonstrated his technique of OPCAB in different places in India and around the world. Recently Dr Murali & his Team performed the FIRST MICS - OPCAB- TAR in India in Nov 2017 using indigenous instrumentation. A Make in India initiative!!
Currently Adjunct Professor in Pulmonology at the Faculty of Health Sciences, University of the Witwatersrand, and Head of the Division of Pulmonology at Chris Hani Baragwanath Academic Hospital in Johannesburg, South Africa.
William is a Pulmonary Consultant Physician and Head of the Division of Pulmonary Medicine at Mulago National Referral Hospital. He is an Honorary Senior Lecturer at Makerere College of Health Sciences, Kampala, Uganda and a founder member of Uganda Thoracic Society. He is a member of Pan African Thoracic Society and the American Thoracic Society. His research interest is in pulmonary complications of HIV, including tuberculosis and the HIV-TB immune reconstitution syndrome. He has been involved in translational and epidemiologic studies identifying causes of pneumonia in HIV-infected patients who are sputum acid fast bacilli negative, and studying the causes of morbidity and mortality among patients with TB and HIV. He has served as PI on a European and Developing Countries Clinical Trials Partnership study: “Early Clinical and Immunological Outcomes of Patients with HIV/TB co-Infections on Antiretroviral Therapy.” And he has collaborated on NIH-funded research studies in HIV-related pulmonary diseases for 10 years.
Heather Zar is Professor and Head of the Department of Paediatrics and Child Health, Director of the School of Child and Adolescent Health at Red Cross Childrens Hospital at UCT. She is Director of the MRC Unit on Child & Adolescent Health. Her work on childhood respiratory diseases, including pneumonia, tuberculosis, asthma and HIV-associated lung diseases has been internationally recognized; she has published more than 250 peer reviewed publications and has substantial international grant support. She currently serves as President of the Pan African Thoracic Society and on the Forum of International Respiratory Societies. She received the World Lung Health award in 2014.